棘手问题：抗血小板药物使用者需要了解的关于抗凝剂和癌症患者的知识
Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer.
作者信息
Adams Val R
机构信息
University of Kentucky, Lexington, Kentucky.
出版信息
J Adv Pract Oncol. 2021 Apr;12(3):262-265. doi: 10.6004/jadpro.2021.12.3.8. Epub 2021 Apr 1.
Abstract
During the JADPRO Live Virtual 2020 conference, Val R. Adams, PharmD, FCCP, FHOPA, BCOP, discussed how to determine which patients with cancer should be treated with direct oral anticoagulants (DOACs), the similarities and differences between the DOACs, and recent data on the prevention and treatment of cancer-associated venous thromboembolism.
摘要
在2020年JADPRO现场虚拟会议期间，药学博士、美国临床药学学院院士、美国肿瘤药学协会会员、肿瘤学认证药师瓦尔·R·亚当斯讨论了如何确定哪些癌症患者应使用直接口服抗凝剂（DOACs）进行治疗、DOACs之间的异同，以及癌症相关静脉血栓栓塞预防和治疗的最新数据。
相似文献
1
Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer.棘手问题：抗血小板药物使用者需要了解的关于抗凝剂和癌症患者的知识
J Adv Pract Oncol. 2021 Apr;12(3):262-265. doi: 10.6004/jadpro.2021.12.3.8. Epub 2021 Apr 1.
2
Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know.直接口服抗凝剂与癌症血栓形成：抗凝药师需要了解的内容
J Adv Pract Oncol. 2022 Apr;13(3):253-256. doi: 10.6004/jadpro.2022.13.3.14. Epub 2022 May 23.
3
Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.直接口服抗凝剂治疗的抗磷脂综合征患者血栓形成风险增加。来自国际患者水平数据荟萃分析的结果。
Autoimmun Rev. 2018 Oct;17(10):1011-1021. doi: 10.1016/j.autrev.2018.04.009. Epub 2018 Aug 11.
4
Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.抗磷脂综合征中直接口服抗凝剂：随机对照试验的荟萃分析。
Autoimmun Rev. 2021 Jan;20(1):102711. doi: 10.1016/j.autrev.2020.102711. Epub 2020 Nov 13.
5
Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.抗磷脂综合征患者的直接口服抗凝剂：一项队列研究。
Lupus. 2020 Jan;29(1):37-44. doi: 10.1177/0961203319889156. Epub 2019 Nov 22.
6
2019-2020 Drug Updates in Hematologic Malignancies.2019 - 2020年血液系统恶性肿瘤的药物更新
J Adv Pract Oncol. 2021 Apr;12(3):279-283. doi: 10.6004/jadpro.2021.12.3.12. Epub 2021 Apr 1.
7
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.静脉血栓栓塞症与癌症：直接口服抗凝剂的现状与未来。
Thromb Res. 2019 May;177:33-41. doi: 10.1016/j.thromres.2019.02.031. Epub 2019 Feb 27.
8
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.直接口服抗凝剂用于抗磷脂抗体综合征患者的血栓预防。
Semin Thromb Hemost. 2018 Jul;44(5):427-438. doi: 10.1055/s-0036-1597902. Epub 2017 Feb 14.
9
Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?直接口服抗凝剂：现在也可用于预防和治疗癌症相关静脉血栓栓塞症？
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):136-143. doi: 10.1182/asheducation-2017.1.136.
10
Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants.直接口服抗凝剂时代静脉血栓栓塞症治疗的最新进展
F1000Res. 2017 Jun 23;6:985. doi: 10.12688/f1000research.11174.1. eCollection 2017.
本文引用的文献
1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.阿哌沙班治疗与癌症相关的静脉血栓栓塞症。
N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29.
2
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.利伐沙班预防高风险门诊癌症患者血栓栓塞症。
N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630.
3
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.阿哌沙班预防癌症患者静脉血栓栓塞症。
N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.
4
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).癌症合并静脉血栓栓塞症患者中口服 Xa 因子抑制剂与低分子肝素的比较：一项随机试验（SELECT-D）的结果。
J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10.
5
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.依度沙班治疗癌症相关静脉血栓栓塞症。
N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.
6
Development and validation of a predictive model for chemotherapy-associated thrombosis.化疗相关性血栓形成预测模型的开发与验证
Blood. 2008 May 15;111(10):4902-7. doi: 10.1182/blood-2007-10-116327. Epub 2008 Jan 23.
Zotero 插件